North America Bioreactors Market Share, Trend, Segmentation and Forecast to 2025

Development of orphan drugs and personalized medicine should provide effective healthcare solutions by improvements in diagnosis, treatment, and monitoring of chronic diseases. Increasing number of personalized medicines targeting a specific population coupled with rising number of FDA approved orphan drugs has increased bioproduction, accelerating the bioreactors demand over the forecast years.

Request for a sample of this report @ https://www.graphicalresearch.com/request/1222/sample

According to the Graphical Research new growth forecast report titled North America Bioreactors Market By Technology (Wave-induced Motion SUB, Stirred SUB, Single Use Bubble Column), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells) estimated to exceed USD 790 million by 2025.

Rising prevalence of chronic diseases, and growing biopharmaceutical investments will drive the global bioreactors market size. Increasing demand for therapeutically effective vaccines, product innovation, and favorable government initiatives to improve healthcare infrastructure will further stimulate business growth. Moreover, various advancements in tank design to meet the growing needs of biopharmaceutical industry will be conducive to the market growth.

Make an Inquiry for purchasing this Report @ https://www.graphicalresearch.com/request/1222/inquiry-before-buying

However, regulatory concerns regarding single-use bioreactor, vulnerability to leaching, and limited storage capacity should hinder bioreactor market growth. Additionally, large-scale disposal of plastic derivatives is a growing environmental concern restraining the business growth over the forecast years.

Mammalian cells segment is estimated to expand at 17.9% CAGR over the forecast timeframe, owing to its wide application in production of viral vaccines and therapeutic proteins. Additionally, emergence of gene therapy and tissue engineering coupled with demand for smart and regenerative medicine should boost the industry growth over the forecast years.

Monoclonal antibodies (mAb) generated over USD 100 million in 2018 owing to its increasing application in treatment of breast cancers, asthma, rheumatoid arthritis, leukemia, psoriasis chronic gastrointestinal inflammatory disease, and transplant rejection. Novel bioreactors that meet specific demands for mAb production will accelerate the segment growth.

Browse Table of Contents @ https://www.graphicalresearch.com/table-of-content/1222/north-america-bioreactors-market

Wave-induced motion SUB segment is expected to witness substantial growth rate of 17.3% across the forecast timeframe. High growth is attributed to extensive use in modern biotechnological processes. It is mainly used in laboratory and pilot plant scale-up owing to better flexibility with adequate productivity. Furthermore, increasing focus of manufacturers in the development of advanced technology related to bioreactors will propel market growth.

R&D organizations segment was valued at USD 127.9 million in 2018 and is projected to witness strong growth over the forecast years. High growth is attributed to increase in number of biopharmaceutical products in pipeline including antibodies and antibody drug conjugates coupled with rising number of new facilities to meet the production needs. Furthermore, large biopharmaceutical companies and biosimilar producers are entering strategic collaborations with new entrants to facilitate business expansion.

North America bioreactors market was led by U.S. bioreactors market and is estimated to show a positive trend throughout the projection period. Canada bioreactors business is forecasted to follow U.S. bioreactors market progressing at 17.9% CAGR throughout the forecast timeframe. High growth is attributed to factors such as presence of major market players, increasing application of single use bioreactor in biopharmaceutical companies and technological innovations to develop disposable bioreactor.

Major market players in North America bioreactors market are Thermo Fisher Scientific, PBS Biotech, GE Healthcare, Merck Group, Cellexus Ltd, Sartorius Stedim Biotech Group and Applikon Biotechnology, Inc., These market players are undertaking strategies such as technology development and acquisitions to gain market presence for company expansion.

Browse key industry insights from this Report @ https://www.graphicalresearch.com/industry-insights/1222/north-america-bioreactors-market

North America Bioreactors Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

North America Bioreactors Market Value, By Cell, 2014-2025, (USD Million)
Mammalian cells
Bacterial cells
Yeast cells
Others

North America Bioreactors Market Size, By Molecule, 2014-2025, (USD Million)
Monoclonal antibodies
Vaccines
Recombinant protein
Stem cell
Gene therapy
Others

North America Bioreactors Market Share, By Technology, 2014-2025, (USD Million)
Wave-induced motion SUB
Stirred SUB
Stirred-use bubble column
Others

North America Bioreactors Market Forecast, By End-use, 2014-2025, (USD Million)
Research and development (R&D) organizations
Biopharma manufacturers
Contract manufacturing organizations (CMOs)

Contact Us:
Parikhit B.
Corporate sales,
Graphical Research
Email: sales@graphicalresearch.com
Web: https://www.graphicalresearch.com

About Graphical Research:
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

This release was published on openPR.